News

Two teams investigated whether an antisense oligonucleotide drug that turns off the ATXN2 gene could be used as a potential therapy in mouse models of these diseases.

A strategic agreement between Europe’s flagship laboratory for basic research in molecular biology and the world’s largest medicinal chemistry design house.

The current OEM agreement is expanded to cover two additional product lines, with an expected annual revenue contribution now more than EUR 1M.

An international team has developed a new approach to protect stem cell recipients from graft-versus-host disease.

MSF publishes a multi-site evaluation of HIV RDTs and risk factors for false positives, which confirms that the diagnosis of HIV should be based on a combination of HIV tests.

Ingestible sensors the size of a vitamin pill could offer a reliable diagnostic tool for a range of gastrointestinal disorders.

When one death in four in the United States is due to cancer, progress against this terrible disease is important news.

Researchers at Monash University solve structure of drug target for osteoperosis, diabetes and obesity.

Combining Metrion's electrophysiological expertise and screening capability with Venomtech's compound library and venom-based drug discovery expertise will rapidly exploit and develop novel tools for ion channel drug discovery research.

Research from the University of Boston suggests that excess sugar, especially the fructose in sugary drinks, might damage your brain.